Title: The Effect of the Granisetron and Ramosetron on the Prevention of Postoperative Nausea and Vomiting during Intravenous Patient Controlled Analgesia with Fentanyl after Total Knee Replacement Surgery
Abstract: Background: Nausea and vomiting are one of the most distressing side effects in patient controlled analgesia using opioids. Both granisetron and ramosetron, selective 5-hydroxytryptamine type 3 receptor antagonists, were studied for the prevention of the postoperative nausea and vomiting (PONV) that may occur during intravenous patient controlled analgesia (IV -PCA) using fentanyl and ketorolac. Methods: Ninety patients receiving total knee replacement surgery under isoflurane anesthesia were randomly allocated to one of three groups. Each group was administered one of the aforementioned drugs mixed with their PCA solutions; saline, granisetron 3 mg or ramosetron 0.3 mg, respectively. The postoperative pain was controlled by IV-PCA, with fentanyl 20 /kg and ketorolac 3 mg/kg in normal saline (total volume; 100 ml, basal rate; 1.5 ml/h, volume of bolus doses; 1 ml, lockout interval; 10 min). The pain scores, frequencies of rescue analgesics requirement, incidence of vomiting, cumulated doses of fentanyl, incidence of severe nausea requiring additional antiemetics and the severity scores for nausea were checked up to second postoperative day by a blind observer. Results: The severity score for postoperative nausea was low in the granisetron and ramosetron groups compared with saline control group (P
Publication Year: 2004
Publication Date: 2004-01-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot